Publications by authors named "Oliver Denton"

Acute recurrent tonsillitis is a chronic, biofilm-related infection that is a significant burden to patients and healthcare systems. It is often treated with repeated courses of antibiotics, which contributes to antimicrobial resistance. Studying biofilms is key to understanding this disease.

View Article and Find Full Text PDF

Purpose: Magnification with accurate optic reproduction of the surgical field is essential in otology surgery, but current technologies are subject to specific disadvantages. This study aims to evaluate a novel 3D digital stereo viewer, the Deep Reality Viewer (DRV), in otology surgery, in comparison to both a 2D monitor and the gold standard of microscopy.

Methods: In this prospective clinical research study, ENT consultants and trainees evaluated visual and practical applications of the DRV.

View Article and Find Full Text PDF

Purpose: This study aimed to report the uptake of hysterectomy and/or bilateral salpingo-oophorectomy (BSO) to prevent gynaecological cancers (risk-reducing surgery [RRS]) in carriers of pathogenic MMR (path_MMR) variants.

Methods: The Prospective Lynch Syndrome Database (PLSD) was used to investigate RRS by a cross-sectional study in 2292 female path_MMR carriers aged 30-69 years.

Results: Overall, 144, 79, and 517 carriers underwent risk-reducing hysterectomy, BSO, or both combined, respectively.

View Article and Find Full Text PDF

Purpose: To determine impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) on gynecological cancer incidence and death in heterozygotes of pathogenic MMR (path_MMR) variants.

Methods: The Prospective Lynch Syndrome Database was used to investigate the effects of gynecological risk-reducing surgery (RRS) at different ages.

Results: Risk-reducing hysterectomy at 25 years of age prevents endometrial cancer before 50 years in 15%, 18%, 13%, and 0% of path_MLH1, path_MSH2, path_MSH6, and path_PMS2 heterozygotes and death in 2%, 2%, 1%, and 0%, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Lynch syndrome is caused by certain gene changes (MLH1, MSH2, MSH6, PMS2) that can lead to different kinds of cancer risks depending on the gene and gender.
  • A study looked at 6,350 people with these gene changes to find out more about their specific cancer risks and survival rates.
  • They found that MLH1 and MSH2 carriers had higher cancer risks, especially for colorectal and endometrial cancers, while MSH6 mainly increased endometrial cancer risk, and not much for PMS2. Most people lived over 10 years after getting treated for these cancers.
View Article and Find Full Text PDF